Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04981223 · ClinicalTrials.gov registry record · NA
Predicting Location and Extent of Prostate Cancer Using Micro-Ultrasound Imaging
A NA study of Prostate Cancer, sponsored by Stanford University.
- Active
- Registry status
- NA
- Development phase
- 95
- Enrollment target
- 1
- Study location
NCT04981223: Active NA study of Prostate Cancer, sponsored by Stanford University.
NCT04981223 is a NA study of Prostate Cancer that is active but no longer recruiting, run by Stanford University. The registered enrollment target is 95 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04981223, a NA study of Prostate Cancer, is active but no longer recruiting, sponsored by Stanford University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 95 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to use a clinical micro-ultrasound to systematically image the prostate before biopsy or surgery. The images from the ultrasound system will be saved and compared to other imaging modalities and pathology in order to develop better tools.
Conditions Studied
Interventions
- DEVICE ExactVu
Study Locations (1)
California
- Stanford University - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 95 participants |
| Start Date | 2022-04-01 |
| Est. Completion | 2025-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04981223
The ClinicalTrials.gov registry entry for NCT04981223 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 95 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (84% lower). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 1 intervention - of which ExactVu is the first listed.
NCT04981223 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT04981223 about?
NCT04981223 is a clinical study titled "Predicting Location and Extent of Prostate Cancer Using Micro-Ultrasound Imaging". The goal of this study is to use a clinical micro-ultrasound to systematically image the prostate before biopsy or surgery. The images from the ultrasound system will be saved and compared to other imaging modalities and pathology in order to develop better tools.
What is the current status of trial NCT04981223?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 95 participants. The study started on 2022-04-01. Estimated completion is 2025-12.
What conditions does trial NCT04981223 study?
This clinical trial studies the following conditions: Prostate Cancer.
What interventions are being tested in trial NCT04981223?
The interventions under investigation include: ExactVu (DEVICE).
Who is sponsoring clinical trial NCT04981223?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04981223 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Prostate Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Improving Health Literacy in African-American Prostate Cancer Patients
RECRUITING · NA
-
Pilot Study to Investigate Magnetic Resonance (MR) Image Guided Focal Therapy in Prostate Cancer
RECRUITING · NA
-
Diffusion Basis Spectrum Imaging of the Prostate
RECRUITING · NA
-
Micro-UltraSound In Cancer - Active Surveillance
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
-
SBRT Boost for Unfavorable Prostate Cancer'
RECRUITING · NA
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.